Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase 3 14Phase 1/2 10Phase 4 4Phase 1 2Phase NA 1

Status

Completed 3Terminated 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Carcinoma, Non-Small-Cell Lung 3Caucasian Patients With EGFR Mutation Positive Advanced NSCLC 1Carcinoma 1

Interventions

Saline Solution 10Docetaxel 10Bevacizumab 9nilotinib 8enzalutamide 8Paclitaxel 8Letrozole 8Fentanyl 8Everolimus 8Cyclophosphamide 8Carboplatin 8Bupivacaine 8Lidocaine 7Sodium Chloride 6Oxycodone 6Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 6Erlotinib Hydrochloride 6Dexamethasone 6Capecitabine 6Trastuzumab 5Tobacco Use Cessation Devices 5Surveys and Questionnaires 5Nivolumab 5Hydromorphone 5Adalimumab 5fludarabine 4Zoledronic Acid 4Tranexamic Acid 4Tacrolimus 4Rocuronium 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Has results × Gefitinib × Clear all
NCT01203917 2017-01-02

IFUM

AstraZeneca

Phase 4 Completed
1,060 enrolled 14 charts
Thoracic

Caucasian Patients With EGFR Mutation Positive Advanced NSCLC

NCT00770588 2016-02-08

INFORM

AstraZeneca

Phase 4 Completed
296 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00536107 2013-10-01

Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

AstraZeneca

Phase 4 Terminated
14 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00608868 2012-09-28

SELINE

AstraZeneca

Phase 4 Completed
156 enrolled 14 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡